ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

721
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
bullish•Celltrion
•30 Jul 2026 06:55•Broker

Celltrion (068270 KS/Buy)Top-tier performance, yet still undervalued vs. peers

We derived our target price for Celltrion by applying a target EV/EBITDA of 28x to our 12-month forward EBITDA estimate of W2.29tr.

Logo
125 Views
Share
bullish•Celltrion Inc
•08 Jan 2026 08:05•Broker

Celltrion (068270 KS/Buy)Consensus Miss Unlikely to Be Repeated This Year

We derived our target price for Celltrion by applying a target EV/EBITDA of 30x to our 12- month forward EBITDA estimate of W1.97tr.

Logo
235 Views
Share
bullish•Celltrion Inc
•06 Nov 2025 19:34•Broker

Celltrion (068270 KS/Buy)Cost Ratio Continues to Improve

Our target price for Celltrion is based on our 12-month forward EBITDA estimate of W1.87tr and a target EV/EBITDA of 27x.

Logo
258 Views
Share
x